XML 35 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Selected Quarterly Data (Unaudited)
 12 Months Ended
Mar. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Data (Unaudited)
Selected Quarterly Data (Unaudited)

The following table presents selected quarterly financial data for the year ended March 31, 2017 and the period from February 2, 2016 (Date of Inception) to March 31, 2016.

 
First Quarter Ended
 
Second Quarter Ended
 
Third Quarter Ended
 
Fourth Quarter Ended
 
Period from February 2, 2016 (Date of Inception) to
 
June 30,
 
September 30,
 
December 31,
 
March 31,
 
March 31,
 
2016 (1)
 
2016
 
2016
 
2017
 
2016
Total operating expenses
$
17,135

 
$
6,720

 
$
9,056

 
$
22,946

 
$
1,657

Net loss
(18,970
)
 
(34,712
)
 
(8,083
)
 
(21,675
)
 
(1,657
)
Net loss per share attributable to common shareholders - basic and diluted
(0.47
)
 
(0.82
)
 
(0.15
)
 
(0.37
)
 
(0.04
)
 
 
 
 
 
 
 
 
 
 

(1)
On April 29, 2016, the Company entered into a license agreement with Takeda. As a result of this transaction, the Company recorded $13.1 million as research and development expense at the closing date of the acquisition of the rights, which consisted of $7.7 million for the estimated fair value of the 5,077,001 common shares issued and $5.4 million for the estimated fair value of warrant liability. Please refer to Note 3 for further details.